Insmed (INSM) Reports In-Line Q2 EPS
Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.48), in-line with the analyst estimate of ($0.48).
For earnings history and earnings-related data on Insmed (INSM) click here.
Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.48), in-line with the analyst estimate of ($0.48).
For earnings history and earnings-related data on Insmed (INSM) click here.